Literature DB >> 14513058

Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin.

H Tamaki, K Ikegame, M Kawakami, T Fujioka, A Tsuboi, Y Oji, Y Oka, H Sugiyama, I Kawase, H Ogawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14513058     DOI： 10.1038/sj.leu.2403092

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients.

Authors:  Kazuhiro Ikegame; Katsuji Kaida; Satoshi Yoshihara; Masayuki Fujiwara; Kyoko Taniguchi; Ruri Kato; Takayuki Inoue; Tatsuya Fujioka; Hiroya Tamaki; Masaya Okada; Toshihiro Soma; Norihiko Kamikonya; Hiroh Saji; Shozo Hirota; Hiroyasu Ogawa
Journal:  Int J Hematol       Date:  2012-05-25       Impact factor: 2.490

2.  Unmanipulated reduced-intensity stem cell transplantation from a haploidentical donor mismatched at 3 HLA antigens to a patient with leukemic transformation of myelodysplastic syndrome: successful second transplantation after graft rejection.

Authors:  Eui Ho Kim; Kazuhiro Ikegame; Manabu Kawakami; Sumiyuki Nishida; Tatsuya Fujioka; Yuki Taniguchi; Tomoki Masuda; Yoshihiro Oka; Ichiro Kawase; Hiroyasu Ogawa
Journal:  Int J Hematol       Date:  2004-12       Impact factor: 2.490

3.  Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine.

Authors:  Juanita Shaffer; Jean Villard; Terry K Means; Stephen Alexander; David Dombkowski; Bimalangshu R Dey; Steven McAfee; Karen K Ballen; Susan Saidman; Frederic I Preffer; David H Sachs; Thomas R Spitzer; Megan Sykes
Journal:  Exp Hematol       Date:  2007-07       Impact factor: 3.084

4.  Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study.

Authors:  Kazuhiro Ikegame; Katsuji Kaida; Keiko Fukunaga; Yuko Osugi; Kyoko Yoshihara; Satoshi Yoshihara; Shinichi Ishii; Satoshi Fujino; Takaya Yamashita; Azusa Mayumi; Satoshi Maruyama; Masahiro Teramoto; Takayuki Inoue; Masaya Okada; Hiroya Tamaki; Hiroyasu Ogawa; Yosihiro Fujimori
Journal:  Bone Marrow Transplant       Date:  2020-06-20       Impact factor: 5.483

5.  Severe acute radiation syndrome: treatment of a lethally 60Co-source irradiated accident victim in China with HLA-mismatched peripheral blood stem cell transplantation and mesenchymal stem cells.

Authors:  Mei Guo; Zheng Dong; Jianhui Qiao; Changlin Yu; Qiyun Sun; Kaixun Hu; Guangxian Liu; Li Wei; Bo Yao; Qiuhong Man; Xuedong Sun; Zhiqing Liu; Zhiwu Song; Chengze Yu; Ying Chen; Qingliang Luo; Sugang Liu; Hui-Sheng Ai
Journal:  J Radiat Res       Date:  2013-08-26       Impact factor: 2.724
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.